News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ansell Healthcare Selects Neoforma, Inc. (NEOF) For Comprehensive Distributor Sales Tracing And Rebate Processing


10/19/2005 5:13:17 PM

SAN JOSE, Calif. and RED BANK, N.J., Oct. 4 /PRNewswire/ -- Ansell Healthcare Products LLC, a global leader in healthcare barrier protective products, has partnered with Neoforma, Inc., , a leading provider of healthcare supply chain management solutions, to support Ansell's data procurement and cleansing efforts.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030226/NEOFORMALOGO )

Ansell will leverage the proven suite of services and solutions offered through Neoforma Contract Management Solution(TM) (Neoforma CMS). Neoforma CMS includes reliable data procurement and cleansing services, precise contract/chargeback validation processing and reporting, and powerful sales trend analysis and reporting through Neoforma SalesTrace(TM). The complexity of the medical/surgical marketplace -- with its distribution requirements, contracting practices with group purchasing organizations (GPOs) and contract administration fees -- has created a critical need for clean and consistent data to ensure the accuracy of chargeback and payment of administration fees and business accounting practices.

"The precision and integrity of sales data is paramount to Ansell's ability to grow its sales revenue and profitability. Neoforma has a proven track record of success in helping healthcare manufacturers like us stay ahead in the market, and we are looking forward to reaping the benefits of the entire suite of Neoforma CMS tools and technology," says William Reed, senior vice president and regional director of the Americas for Ansell, which celebrates more than 100 years as a market leader.

Neoforma performs the steps necessary to simplify an otherwise highly complex contract management and chargeback process for medical/surgical manufacturers. Through Neoforma CMS, the Neoforma team procures data seamlessly from distributors, and cleans and standardizes the data by detecting duplicate transactions, filling in missing fields and correcting inconsistencies.

"Ansell joins other leading suppliers that recognize that sales success relies upon a foundation of clean and accurate data, which Neoforma CMS provides. We are proud to be Ansell's supply chain partner in its efforts to optimize its sales strategies for peak performance," says Dan Eckert, president and chief operating officer of Neoforma.

About Ansell

Ansell Ltd is a global leader in healthcare barrier protective products. With operations in the Americas, Europe, and Asia, Ansell employs more than 11,000 people worldwide and holds leading positions in the natural latex and latex-free glove and condom markets. Ansell operates in three main business segments: Occupational Healthcare, supplying hand protection to the industrial market; Professional Healthcare, supplying surgical and examination gloves to healthcare professionals; and Consumer Healthcare, supplying sexual health products and consumer hand protection. Information on Ansell and its products can be found at www.ansell.com.

About Neoforma

Neoforma is a leading supply chain management solutions provider for the healthcare industry. Through a unique combination of technology, information, and services, Neoforma provides innovative solutions to over 1,600 hospitals and suppliers, supporting more than $13 billion in annualized transaction volume. By bringing together contract information and order data, Neoforma's integrated solution set delivers a comprehensive view of an organization's supply chain, driving cost savings and better decision-making for both hospitals and suppliers. For more information, point your browser to www.neoforma.com.

This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements related to Ansell leveraging the proven suite of services and solutions offered through Neoforma CMS, Neoforma ability to perform the steps necessary to simplify an otherwise highly complex contract management and chargeback process for medical/surgical manufacturers, and ability of Neoforma CMS to provide clean and accurate data. There are a number of risks that could cause actual results to differ materially from those anticipated by these forward-looking statements. These risks include the costs associated with providing the services expected by Neoforma customers, the outcome of Neoforma's evaluation of strategic alternatives and the ability of Neoforma to manage its technological challenges. Some of these risks and other risks are described in Neoforma's periodic reports filed with the SEC, including its Form 10-Q for the quarter ended June 30, 2005. These statements are current as of the date of this release and Neoforma assumes no obligation to update the forward-looking information contained in this news release.

NOTE: Neoforma is a trademark of Neoforma, Inc. Other Neoforma logos, product names and service names are also trademarks of Neoforma, Inc., which may be registered in other countries. Other product and brand names are trademarks of their respective owners.

Photo: http://www.newscom.com/cgi-bin/prnh/20030226/NEOFORMALOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk,photodesk@prnewswire.comNeoforma, Inc.

CONTACT: media, Rebecca Oles, +1-408-468-4363, orrebecca.oles@neoforma.com, or investors, Amanda Mogin, +1-408-468-4251, oramanda.mogin@neoforma.com, both of Neoforma; or media, Erin Foster ofAnsell, +1-732-389-4500, or efoster@lanmarkgroup.com, for Neoforma


Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES